Drugs for COVID-19
CURRENT
ISSUE
1653

This article includes recommendations for management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have not been approved by the FDA (see Table 1).

PARTNER TREATMENT — Management of all STIs should include evaluation of recent sex partners of infected persons. If possible, partners should be examined and tested for STIs, but in most cases partner treatment of bacterial STIs and trichomoniasis should be started regardless of symptoms...  Continue reading

Coming Soon
Daridorexant (Quviviq) for Insomnia
Tirzepatide (Mounjaro) for Type 2 Diabetes
Oteseconazole (Vivjoa) for Vulvovaginal Candidiasis/150